Latab, Nanie S.

HRN: 13-82-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/27/2025
01/03/2026
IV
4.5gms
Q8
CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines